Latest News
CHMP issues positive opinion for DAWNZERA in hereditary angioedema
14 November 2025 - Ionis Pharmaceuticals Inc (Nasdaq:IONS), a US-based provider of RNA-targeted medicines, and Japanese healthcare company Otsuka Pharmaceutical Co Ltd announced on Friday that the Committee for Medicinal Products for Human Use (CHMP)...
Merck to acquire Cidara Therapeutics in USD9.2bn deal to expand antiviral portfolio
14 November 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Friday announced a definitive agreement to acquire Cidara Therapeutics Inc (Nasdaq:CDTX), a biotechnology company developing drug-F...
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
14 November 2025 - US-based based generic pharmaceutical company Ingenus Pharmaceuticals announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its Conjugated Estrogens Tablets, USP, the first FDA-appro...
Eisai and BioArctic's Leqembi gains UK regulatory approval for IV maintenance treatment of Alzheimer's disease
14 November 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Thursday that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved Le...
IVI RMA Global Expands Footprint with Acquisition of ART Fertility Clinics, Establishing Middle East as Fifth Operating Region
14 November 2025 - IVI RMA Global, recognised as the world's leading reproductive medicine platform, has confirmed that following the completion of its acquisition of ART Fertility Clinics ("ART Fertility") -- operating in the United A...